Yili Chuanning Biotechnology Co.,Ltd. Statistics

Total Valuation

Yili Chuanning Biotechnology Co.,Ltd. has a market cap or net worth of CNY 26.73 billion. The enterprise value is 28.03 billion.

Market Cap	26.73B
Enterprise Value	28.03B

Important Dates

The next estimated earnings date is Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	May 22, 2024

Share Statistics

Yili Chuanning Biotechnology Co.,Ltd. has 2.23 billion shares outstanding. The number of shares has increased by 10.86% in one year.

Shares Outstanding	2.23B
Shares Change (YoY)	+10.86%
Shares Change (QoQ)	+4.54%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	4.42%
Float	432.67M

Valuation Ratios

The trailing PE ratio is 20.80 and the forward PE ratio is 18.37.

PE Ratio	20.80
Forward PE	18.37
PS Ratio	4.89
PB Ratio	3.68
P/FCF Ratio	36.01
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.96, with an EV/FCF ratio of 37.77.

EV / Earnings	21.30
EV / Sales	5.00
EV / EBITDA	12.96
EV / EBIT	17.29
EV / FCF	37.77

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.31.

Current Ratio	1.92
Quick Ratio	1.41
Debt / Equity	0.31
Debt / EBITDA	1.03
Debt / FCF	3.00
Interest Coverage	21.76

Financial Efficiency

Return on equity (ROE) is 19.25% and return on invested capital (ROIC) is 11.12%.

Return on Equity (ROE)	19.25%
Return on Assets (ROA)	9.95%
Return on Capital (ROIC)	11.12%
Revenue Per Employee	1.94M
Profits Per Employee	456,786
Employee Count	2,881
Asset Turnover	0.55
Inventory Turnover	3.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+35.75%
50-Day Moving Average	11.49
200-Day Moving Average	10.95
Relative Strength Index (RSI)	51.69
Average Volume (20 Days)	26,486,068

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Yili Chuanning Biotechnology Co.,Ltd. had revenue of CNY 5.60 billion and earned 1.32 billion in profits. Earnings per share was 0.58.

Revenue	5.60B
Gross Profit	1.94B
Operating Income	1.62B
Pretax Income	1.56B
Net Income	1.32B
EBITDA	2.15B
EBIT	1.62B
Earnings Per Share (EPS)	0.58

Full Income Statement

Balance Sheet

The company has 929.12 million in cash and 2.22 billion in debt, giving a net cash position of -1.30 billion or -0.58 per share.

Cash & Cash Equivalents	929.12M
Total Debt	2.22B
Net Cash	-1.30B
Net Cash Per Share	-0.58
Equity (Book Value)	7.27B
Book Value Per Share	3.26
Working Capital	1.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.03 billion and capital expenditures -286.39 million, giving a free cash flow of 742.18 million.

Operating Cash Flow	1.03B
Capital Expenditures	-286.39M
Free Cash Flow	742.18M
FCF Per Share	0.33

Full Cash Flow Statement

Margins

Gross margin is 34.71%, with operating and profit margins of 28.95% and 23.49%.

Gross Margin	34.71%
Operating Margin	28.95%
Pretax Margin	27.80%
Profit Margin	23.49%
EBITDA Margin	38.42%
EBIT Margin	28.95%
FCF Margin	13.25%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.77%.

Dividend Per Share	0.22
Dividend Yield	1.77%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	42.53%
Buyback Yield	-10.86%
Shareholder Yield	-9.09%
Earnings Yield	4.81%
FCF Yield	2.78%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Yili Chuanning Biotechnology Co.,Ltd. has an Altman Z-Score of 5.43.

Altman Z-Score	5.43
Piotroski F-Score	n/a